|

mBU/CY and ATG Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2/3: 1

Top Sponsors

  • Peking University People's Hospital1

Indications

  • Leukemia Relapse1
  • Stem Cell Transplant Complications1
  • Leukemia, Myeloid, Acute1
  • Cancer1

Other1 trial

Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.